[QUICKREADS]

World News
Swipe up for the next story
A handout video grab image shows the production process of Shionogi & Co Ltd's ongoing clinical trial of pills, known as S-217622, for the oral coronavirus disease (COVID-19) treatment.

Japanese drug maker says Covid-19 pill shows rapid clearance of virus

An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday. The pill, S-217622, "demonstrated rapid clearance of the infectious SARS-CoV-2 virus", Shionogi said in a statement, citing Phase-2b results from the Phase II/III clinical trial of the drug. Shionogi's shares have been on a rollercoaster on speculation about success of the treatment.

Story Saved
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Tuesday, February 07, 2023
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals